#
Ingrezza
  • Treatments
  • Tardive Dyskinesia

Ingrezza

Generic name:valbenazineval-BEN-a-zeen ]
Drug class:VMAT2 inhibitors

Medically reviewed by Philip Thornton, DipPharm. Last updated on Aug 2, 2021.

What is Ingrezza?

Ingrezza blocks certain chemicals in the body that may be involved with involuntary muscle movement.

Ingrezza is used to treat symptoms of tardive dyskinesia, a nervous system disorder. Tardive dyskinesia causes repetitive uncontrolled muscle movements, usually in the face (chewing, lip smacking, frowning, tongue movement, blinking or eye movement).

Ingrezza is not a permanent cure for this condition.

Warnings

Do not breastfeed while using Ingrezza and for at least 5 days after your last dose.

Before taking this medicine

You should not use Ingrezza if you are allergic to valbenazine.

To make sure this medicine is safe for you, tell your doctor if you have ever had:

  • heart disease;

  • long QT syndrome or other heart rhythm disorder;

  • congestive heart failure;

  • a heart attack;

  • liver disease; or

  • kidney disease.

It is not known whether Ingrezza will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Do not breastfeed while using this medicine and for at least 5 days after your last dose.

Ingrezza is not approved for use by anyone younger than 18 years old.

How should I take Ingrezza?

Take Ingrezza exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

You may take Ingrezza with or without food.

Your heart function may need to be checked...